Balentine LLC Laboratory Corp Of America Holdings Transaction History

Balentine LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$213.86 - $277.87 $245,939 - $319,550	-1,150 Closed	0 $0
Q1 2022 Oct 26, 2022	BUY	$259.82 - $298.18 $298,793 - $342,907	1,150 New	1,150 $303,000
Q1 2022 May 06, 2022	BUY	$259.82 - $298.18 $118,737 - $136,268	457 Added 65.95%	1,150 $303,000
Q4 2021 Oct 26, 2022	BUY	$271.6 - $314.21 $188,218 - $217,747	693 New	693 $218,000
Q4 2021 Feb 02, 2022	BUY	$271.6 - $314.21 $188,218 - $217,747	693 New	693 $218,000
Q3 2020 Nov 02, 2020	SELL	$167.03 - $201.3 $4,843 - $5,837	-29 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$113.31 - $182.44 $226 - $364	-2 Reduced 6.45%	29 $5,000
Q1 2020 May 18, 2020	BUY	$104.32 - $195.28 $1,356 - $2,538	13 Added 72.22%	31 $4,000
Q2 2019 Aug 14, 2019	BUY	$144.16 - $172.9 $2,594 - $3,112	18 New	18 $3,000
Q1 2018 May 16, 2018	SELL	$161.53 - $178.11 $79,149 - $87,273	-490 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$149.47 - $160.56 $73,240 - $78,674	490	490 $74,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

Stay updated on Balentine LLC with notifications on news.